11 Jun 2020 --- Chr. Hansen Holding is set to acquire US-based UAS Laboratories LLC (UAS Labs) for US$530 million. The acquisition of the B2B company specializing in clinically documented probiotics will strengthen and expand Chr. Hansen’s global microbial platform and Human Health business. The company also notes the move is aligned with the strategy of pursuing bolt‐on acquisitions that fit into the microbial platform. The acquisition is still subject to approvals.
